Search
for
Sort by
Research 361–390 of 1000+
- 128 Bimekizumab led to rapid & deep normalisation of molecular signatures associated with PASI sub-components, preceding clinical skin clearance
- Human regulatory γδT lymphocytes as novel autoimmunity-protective cells: Lessons from alopecia areata
- Hair Growth Effect and the Mechanisms of Rosa rugosa Extract in DHT-Induced Alopecia Mice Model
- A Paintable Small-Molecule Hydrogel with Antimicrobial and ROS Scavenging Activities for Burn Wound Healing
- Recent approaches of antibody therapeutics in androgenetic alopecia
- 039 Expansion of regulatory T Cells restrains pathogenic CD8 T Cells in a murine model of alopecia areata
- 371 Hair follicles are critical modulators of skin barrier function
- Adipose tissue remodeling via TSLP-mediated IL-4/IL-13 signaling: Implications for atopic dermatitis and skin barrier
- Features of the clinical course of the disease, quality of life and systemic cytokine profile in patients with chronic true eczema and depression
- Role of Dermal Factors Involved in Regulating the Melanin and Melanogenesis of Mammalian Melanocytes in Normal and Abnormal Skin
- Secretome of Hypoxic Mesenchymal Stem Cells Improves Fluconazole-Induced Alopecia in Rats via Immunoregulatory Modulation of IL-15 and IFN-γ
- Elevation of circulating DNAs of disease-associated cytokines in serum cell-free DNA from patients with alopecia areata
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Study on the Efficacy and Potential Mechanism of Topical Shen Bai Hair Growing Decoction against Androgenetic Alopecia Based on Ultrahigh Performance Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry and RNA-seq
- current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
- 27 Preclinical ex vivo and in vivo evidence supporting selective inhibition of tyrosine kinase 2-dependent, IL-12-mediated signaling as a novel pharmacological strategy for alopecia areata management
- 42905 Role of regulatory T and T-helper 17 cells in patients with acute diffuse and total alopecia
- BH14 Multiple sclerosis and alopecia areata: drug-induced alopecia areata or coexisting autoimmune phenomena?
- ISID1494 - Dual effects of HA-iMSC-exosomes in human follicle dermal papilla cells (HFDPC) on androgenic alopecia in vitro model.
- 219 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid
- 1326 Translation-dependent skin hyperplasia is promoted by type 1/17 inflammation in psoriasis
- 148 Decreased IL-10 producing regulatory B cells in patients with alopecia areata
- 1396 Interferon-24 regulates the expression of MMP1 and dermal collagen of the skin
- 1375 Effects of a new recombinant human collagen on skin aging
- 224 Humoral immune response to COVID-19 vaccination in psoriasis patients on biologic therapy is impaired compared to healthy controls
- 068 Pathogenic Th17 cells, CD8+CD69+CD49a- tissue-resident memory T cells and common γ chain receptor + natural killer cells express more IL-17, compared to IFN-γ, under the foxp3+ memory regulatory T cells-depleted microenvironment in patients with chronic alopecia areata
- Lichen planus – A refractory autoimmune disorder
- 545 Skin Organoids derived from NCSTN mutated patient-induced pluripotent stem cells recapitulate Hidradenitis Suppurativa pathogenic hallmarks
- 013 IL-15/IL-15Rα signaling is a guardian of human hair follicle immune privilege and promotes hair growth
- T helper type 2 immune response in alopecia areata